Navigation Links
Researchers discover new form of cancer gene regulation
Post Your Comments:
(Date:11/4/2009)... DNA codes, or genomes, of the famed fugu (or puff...10K Project, an international effort to build an i...ecies of animals for conducting comparative studie..., Participating in The Genome 10K project, descri... of the Journal of Heredity , are 70 leading scie...
(Date:11/4/2009)...Call/ -- Quest Diagnostics Incorporated (NYSE: DG...sting, information and services, announced that fo...me from continuing operations rose to $192 million...r $0.81 per diluted share, for the third quarter o...d by a $0.03 per share charge associated with the ...
(Date:11/4/2009)...t,s the cost of saving a teenage life? When it com...rescription medication abuse, there,s no price tag...aware that the lock-boxes they,ve installed are no... of prescription drugs. That,s why MEDNET(TM), a n..., has formed an exclusive partnership with Axius H...
Breaking Biology News(10 mins):Singapore scientists join international study of 10,000 vertebrates' genomes 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Leader in Elder Care Award to Posit Science CEO 58186 1Leader in Elder Care Award to Posit Science CEO 58186 2Right to Health Care Debated at New ProCon org Website 58181 1Right to Health Care Debated at New ProCon org Website 58181 2Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 1Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 2Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 3Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 4Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 5Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 6
...Damaged or defective genes have long been known to...e, however, scientists have discovered that even h...se cancer without any changes in the underlying DN...oorly understood. , Researchers in the laborator...ablished a direct causal connection between hyperm...
...nd mineralogy are scientific fields that have been... and technologies. The boundary of water and rock,...field of nanoparticle science. , Scientists are d...00 nanometers, influence natural and engineered wa... materials of a larger size. Nanoparticles are in ...
...chnology recently received a research grant from t...ject, Functional Polymers Modified Surfaces with B...Associate Professor in the Department of Chemistry...Principal Investigator. , A biofilm is an assembla...ted with a surface. Bacteria in biofilm show uniqu...
Other Biology News:DNA methylation shown to promote development of colon tumors 2DNA methylation shown to promote development of colon tumors 3Between water and rock -- a new science 2Between water and rock -- a new science 3Between water and rock -- a new science 4Between water and rock -- a new science 5
(Date:11/5/2009).... 5 The endangered black-footed fe.... This rare carnivore feeds on prairie dogs. Th...often entire population die-offs in towns occur. ...lemented a ferret breeding program and has been re...ly native habitat. Unfortunately, plague can swee...
(Date:11/5/2009)..., Nov. 5 ThermoGenesis C...ative products for processing and storing adult st...rter of fiscal 2010. ,, For the quarter ended S...f $5.2 million, a 15 percent increase over revenue... The Company said the key contributors to the grow...
(Date:11/5/2009)... BioSpecifics Technologi...pany developing first-in-class collagenase-based p... the third quarter ended September 30, 2009. ,...his year, the FDA,s Arthritis Advisory Committee u...roval of XIAFLEX(TM) for the treatment of Dupuytre...
(Date:11/5/2009)...r 5, 2009 Senomyx, Inc. ...ietary taste receptor-based technologies to discov..., and ingredient supply industries, today provided... for the third quarter ended September 30, 2009. ...f 2009, compared to $4.0 million for the third qua...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...3 Frontage Laboratories Inc. ("Frontage"), a lead...inical, clinical and drug development services to ...ounce it has expanded its research and development...e ethical drug division of Beijing Pharmaceutical ...arma,s entrance into the international generic dru...
...Heart patients with acute coronary syndrome (ACS) ...ave a new treatment option to help prevent heart a...8) and Eli Lilly and Company (NYSE: LLY ) announ... marketing authorization for EFIENT (R) (pronounc...atherothrombotic events in patients with ACS under...
... Continues to Successfully Leverage Differentiated... Rochester, New York (PRWEB) February 23, 20...ator in advanced cardiac safety biomakers and auto...y has experienced significant revenue growth as it...ss of 100%. Pharmaceutical and biotechnology comp...
Other Biology Technology:Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent 2Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent 3Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent 4European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 2European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 3European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 4European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 5iCardiac Reports Significant Revenue Growth and Profitability 2iCardiac Reports Significant Revenue Growth and Profitability 3
Phage Display cDNA Library Screening Kit from Spring Bioscience
... an enzymeimmunoassay intended for the quantitativ...nd other hydroxylated metabolites in human serum o...minates the inconvenience of solvent precipitation...mation on many ELISA processors. The kit enables t...
...petitive enzymeimmunoassay (EIA) for the quantitat...t serum or plasma. Corticosterone is the major, if... most non-mammalian vertebrates such as amphibia, ...icosterone and cortisol, in varying proportions. I...
Mouse Anti-Aggrecan xxPEN Monoclonal Antibody, Unconjugated, Clone BC-4 from Abcam
Biology Products: